AAPA

Introduction

Despite the fact that reports of sexual dysfunction are more prevalent among women (39%) than among men (28%), very few women who desire help for their sexual dysfunction actually receive that help. In contrast, men are twice as likely to receive help from their clinicians for their sexual dysfunctions. The current trend toward a greater overall awareness and openness about female sexual dysfunction has not yet made female patients any less reluctant to initiate sexual health discussions with their providers. Participants in this live, interactive program will be provided with guidelines, demonstrations, and practice in how to comfortably incorporate sexual health discussions into visits with their female patients. This activity will provide an overview of diagnosis and potential treatments for hypoactive sexual desire disorder (HSDD), a distressing reduction of sexual desire that is the most frequently reported sexual dysfunction among women. Healthy sexual function significantly raises a woman's sense of well-being and quality of life, and improving sexual health is an important goal in providing health care for female patients.

Assessing the Frontier of Female Sexual Dysfunction: A Look at the Horizon of Improved Diagnosis and Individualized Treatment Approaches of HSDD

Powerpoint Slides

For your convenience, the powerpoint slides for this presentation may be downloaded by clicking here.

CME Credit

This program has been reviewed and is approved for a maximum of 1.25 hours of AAPA Category I CME Credit. After viewing the webcast AAPA Fellow members may complete the post-test by clicking here. Expiration Date: August 2010.

Learning Objectives

1. Increase discussion of female sexual health issues by utilizing communication techniques that facilitate the initiation of sexual health conversations.
2. Incorporate the use of standard questions and checklists into the diagnosis of HSDD.
3. Demonstrate an understanding of how emerging treatment options may be utilized in the individualized management of patients with HSDD

Faculty

Rebecca A. Lehman, MPAS, PA-C
Founder and Past President
Association of Physician Assistants in Obstetrics and Gynecology
Adjunct Professor
Physician Assistant Program
Nova Southeastern University
Naples, FL

Louis Kuritzky, MD
Clinical Assistant Professor
Department of Community Health and Family Medicine
University of Florida
Gainesville, FL

Disclosures

Rebecca A. Lehman, MPAS, PA-C, reported that she serves as a consultant to Novo Nordisk A/S.

Louis Kuritzky, MD, reported that he serves as a speaker for Takeda Pharmaceuticals North America, Inc. and Sucampo Pharmaceuticals, Inc.

Disclosure of Unlabeled or Investigational Drugs

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Statement of Commerical Support

This CME symposium is supported by an educational grant from Boehringer-Ingelheim.